| abstract |
The use of physiologically acceptable enzyme mixtures with lipolytic, proteolytic and amylolytic activity of microbial or animal origin is described, but in particular of digestive enzyme mixtures such as e.g. B. pancreatin or pancreatin-containing digestive enzyme mixtures, for the treatment of diabetes, and for the preparation of medicaments suitable for this treatment. In a variant, the invention relates to the use of these enzyme mixtures with lipolytic, proteolytic and amylolytic activity, but in particular pancreatin or pancreatin-containing digestive enzyme mixtures for the adjuvant treatment of diabetes mellitus of both type I and type II. |